Skip Navigation



BJA Advance Access published online on April 22, 2005

British Journal of Anaesthesia, doi:10.1093/bja/aei138
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/6/843    most recent
aei138v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Akerman, N.
Right arrow Articles by Lyons, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akerman, N.
Right arrow Articles by Lyons, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2005. All rights reserved. For Permissions, please e-mail: journal.permissions@oupjournals.org
Accepted March 6, 2005

Clinical Investigation

Effect of intrathecal diamorphine on block height during spinal anaesthesia for Caesarean section with bupivacaine

N. Akerman 1*, S. Saxena 1, R. Wilson 1, M. Columb 2, and G. Lyons 1

1 Department of Obstetric Anaesthesia, St James' University Hospital, Leeds, UK
2 Intensive Care Unit, South Manchester University Hospital, Wythenshawe, UK

* To whom correspondence should be addressed.
N. Akerman, E-mail: nik_lucy{at}hotmail.com


   Abstract

Background. Opioid analgesics are commonly added to intrathecal bupivacaine to improve patient comfort during Caesarean section under spinal anaesthesia, and provide post-operative pain relief. We sought to discover if the addition of diamorphine influenced block height when given with 0.5% w/v hyperbaric bupivacaine.

Method. Eighty ASA I and II women of at least 37 weeks gestation and planned for elective Caesarean section under combined spinal-epidural anaesthesia were recruited. They were randomized into two groups to receive intrathecal hyperbaric bupivacaine 0.5% at an initial dose of 13 mg, with the next dose determined by the response of the previous patient (dose interval 1 mg). One group also received diamorphine 400 µg intrathecally. If a block height of T5 to blunt light touch had been achieved after 20 min, the block was deemed effective. A difference in the ED50 for hyperbaric bupivacaine between the groups would indicate that diamorphine influenced block height. Intraoperative patient discomfort and need for analgesic supplementation was noted.

Results. The median effective dose (ED50) to achieve a T5 block to light touch for Caesarean section using hyperbaric bupivacaine 0.5% was 9.95 mg [95% confidence interval (CI) 9.0-10.90] and with the addition of diamorphine it was 9.3 mg (95% CI 8.15-10.40), while the ED95 was 13.55 mg (95% CI 10.10-17.0) and 13.6 mg (95% CI 9.15-18.05), respectively. Five women who had received intrathecal diamorphine and 13 who had not received diamorphine needed intraoperative supplementation (not significant).

Conclusion. The addition of intrathecal diamorphine does not appear to influence block height.

Keywords: anaesthetic techniques, epidural; anaesthetics, local, bupivacaine; analgesics, opioid, diamorphine; surgery, Caesarian section.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
D. W. Cooper, S. C. Gibb, T. Meek, S. Owen, M. S. Kokri, A. T. Malik, and K. K. Koneti
Effect of intravenous vasopressor on spread of spinal anaesthesia and fetal acid-base equilibrium
Br. J. Anaesth., May 1, 2007; 98(5): 649 - 656.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. S. Cepeda, D. B. Carr, T. Sarquis, N. Miranda, R. J. Garcia, and C. Zarate
Static Magnetic Therapy Does Not Decrease Pain or Opioid Requirements: A Randomized Double-Blind Trial
Anesth. Analg., February 1, 2007; 104(2): 290 - 294.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.